Mihai Truica

8PUBLICATIONS
42CO-AUTHORS
Biomolecular modelling and designMedical devicesMolecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 18, 2026
A bivalent lysine-acetylated small-molecule binding site in MYC.

Dikshat G Gupta, Mihai I Truica, Adam W T Steffeck

|Feb 24, 2026
Heterobifunctional proteomimetic polymers for targeted degradation of MYC and KRAS.

Max M Wang, Mihai I Truica, Brayley S Gattis

|Jul 16, 2025
Impaired mitochondrial metabolism is a critical cancer vulnerability for MYC inhibitors.

William Yang, Qianyu Guo, Songhua Quan

|Jul 03, 2024
Asparagine Dependency Is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer.

Young A Yoo, Songhua Quan, William Yang

|Jan 08, 2024
Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC.

Sukanya Panja, Mihai Ioan Truica, Christina Y Yu

|Apr 27, 2022
A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression.

Austin G Holmes, J Brandon Parker, Vinay Sagar

Pageof 2

Frequent Collaborators

7 joint publications

Sarki A Abdulkadir

3 joint publications

Vinay Sagar

3 joint publications

William Yang

3 joint publications

Gary E Schiltz